Enhancement of Antitumor Vaccination by Targeting Dendritic Cell-Related IL-10
Understanding mechanisms associated to dendritic cell (DC) functions has allowed developing new antitumor therapeutic vaccination strategies. However, these vaccines have demonstrated limited clinical results. Although the low immunogenicity of tumor antigens used and the presence of tumor-associate...
Main Authors: | Diana Llopiz, Marta Ruiz, Leyre Silva, Pablo Sarobe |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2018.01923/full |
Similar Items
-
Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination
by: David Repáraz, et al.
Published: (2022-10-01) -
The Toll like receptor 4 ligand cold-inducible RNA-binding protein as vaccination platform against cancer
by: Lorea Villanueva, et al.
Published: (2018-04-01) -
Interleukin (IL)-23 Stimulates IFN-γ Secretion by CD56bright Natural Killer Cells and Enhances IL-18-Driven Dendritic Cells Activation
by: Andrea Ziblat, et al.
Published: (2018-01-01) -
Determination Of Interleukine-10 In Cancer Patients In Stages Iii And Iv Treated With Dexamethasone.
by: Heber Siachoque, et al.
Published: (2005-12-01) -
IL-37 induces anti-tumor immunity by indirectly promoting dendritic cell recruitment and activation in hepatocellular carcinoma
by: Liu Y, et al.
Published: (2019-07-01)